IVF Hartmann (Switzerland) Insiders
| VBSN Stock | CHF 151.00 1.00 0.67% |
IVF Hartmann employs about 312 people. The company is managed by 3 executives with a total tenure of roughly 728 years, averaging almost 242.0 years of service per executive, having 104.0 employees per reported executive. Recap of IVF Hartmann's management performance can provide insight into the venture performance.
| Hannes Leu Insider Chief Officer |
| Bernd Deny Insider Chief Officer |
IVF |
IVF Hartmann Management Team Effectiveness
The company has return on total asset (ROA) of 0.0315 % which means that it generated a profit of $0.0315 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0544 %, meaning that it generated $0.0544 on every $100 dollars invested by stockholders. IVF Hartmann's management efficiency ratios could be used to measure how well IVF Hartmann manages its routine affairs as well as how well it operates its assets and liabilities.The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.
IVF Hartmann Holding Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. IVF Hartmann Holding Price Series Summation is a cross summation of IVF Hartmann price series and its benchmark/peer.
IVF Hartmann Notable Stakeholders
An IVF Hartmann stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as IVF Hartmann often face trade-offs trying to please all of them. IVF Hartmann's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting IVF Hartmann's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Hannes Leu | Chief Officer | Profile | |
| Bernd Deny | Chief Officer | Profile | |
| Claus Martini | Chief Officer | Profile |
About IVF Hartmann Management Performance
The success or failure of an entity such as IVF Hartmann Holding often depends on how effective the management is. IVF Hartmann management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of IVF management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the IVF management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland. IVF HARTMANN operates under Medical Instruments Supplies classification in Switzerland and is traded on Switzerland Exchange. It employs 323 people.
Please note, the imprecision that can be found in IVF Hartmann's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of IVF Hartmann Holding. Check IVF Hartmann's Beneish M Score to see the likelihood of IVF Hartmann's management manipulating its earnings.
IVF Hartmann Workforce Analysis
Traditionally, organizations such as IVF Hartmann use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare IVF Hartmann within its industry.IVF Hartmann Manpower Efficiency
Return on IVF Hartmann Manpower
| Revenue Per Employee | 461.8K | |
| Revenue Per Executive | 48M | |
| Net Income Per Employee | 19.9K | |
| Net Income Per Executive | 2.1M |
Additional Tools for IVF Stock Analysis
When running IVF Hartmann's price analysis, check to measure IVF Hartmann's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IVF Hartmann is operating at the current time. Most of IVF Hartmann's value examination focuses on studying past and present price action to predict the probability of IVF Hartmann's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IVF Hartmann's price. Additionally, you may evaluate how the addition of IVF Hartmann to your portfolios can decrease your overall portfolio volatility.